Johnson Winter & Slattery is engaged by major businesses, investment funds and government agencies as legal counsel on important transactions and disputes throughout Australia and surrounding regions.
Our firm provides a diverse range of opportunities for talented, enthusiastic people to develop brilliant legal careers.
Our news and media coverage including major transaction announcements, practitioner appointments and team expansions.
We support a number of community initiatives and not for profit organisations across Australia through pro bono legal work and charitable donations.
We support a number of organisations through sponsorships.
Clare specialises in corporate and public securities law, with a particular focus on equity capital markets and venture capital.
She has experience in cross-border and domestic corporate transactions including advising on equity and hybrid security fundraisings, private financing and investment transactions, regulated and private M&A, business sales and acquisitions, securities regulatory and ASX compliance issues, ESOPs and other general corporate matters.
She regularly acts for companies and investors in the healthcare and biotechnology sector, as well as the technology industry more broadly.
Advised on its A$33.3 million IPO and ASX listing in March 2017.
Advised on its A$36.5 million IPO and ASX listing in 2015 and its follow-on capital raisings in 2016 and 2017.
Advised on its IPO and ASX listing in 2019.
Advised on its non-renounceable entitlement offer in 2019.
Advised on its Series B financing in 2018.
Advised on its investment in OneConfig.
Advised on its investments in Renew Medical and EBR Systems.
Advised on its investment in RangeMe and related redomicile.
Advised on its investment in Popgun.
Advised on various VC investments.
Advised on infant formula joint venture with Bega Cheese in 2016.
Advised on redomicile to Bermuda via scheme of arrangement in 2015.
Acted as Australian counsel on acquisition of Transaction Services Group in 2015.
Advised on implementation of its management incentive plan.
Advice on equity incentive plans.
ASIC and ASX have both announced temporary changes to their respective regulatory regimes to facilitate capital raisings for listed entities in response to the economic impact of COVID-19.
Late last year the Australian Securities Exchange (ASX) released its consultation paper “Simplifying, clarifying and enhancing the integrity and efficiency of the ASX Listing Rules”. After...
What are employee incentive plans and why do employers use them?